UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.__________ )*
Rita Medical Systems, Inc.
--------------------------
(Name of Issuer)
Common Stock
------------
(Title of Class of Securities)
76774E103
---------
(CUSIP Number)
January 24, 2003
----------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
------------------------- ----------------------------------
CUSIP No. 76774E103 13G Page 2 of 6 Pages
----- -----
------------------------- ----------------------------------
-- ----------------------------------------------------------------------------
NAME OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (Entities only)
Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13D-1(k)
-- -----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
Not Applicable.
-- -----------------------------------------------------------------------------
3 SEC USE ONLY
-- -----------------------------------------------------------------------------
4 CITIZENSHIP OF PLACE OF ORGANIZATION
United States of America
-- -----------------------------------------------------------------------------
----------------- ---- ---------------------------------------------------------
NUMBER OF SOLE VOTING POWER
SHARES
BENEFICIALLY
OWNED BY 5 1,136,363
EACH
REPORTING
PERSON
WITH
---- ---------------------------------------------------------
SHARED VOTING POWER
6 0
---- ---------------------------------------------------------
SOLE DISPOSITIVE POWER
7 1,136,363
---- ---------------------------------------------------------
SHARED DISPOSITIVE POWER
8 0
----------------------- --------- ----------------------------------------------
-- -----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,136,363
-- -----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ]
Not applicable.
-- -----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
-- -----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
-- -----------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13G Page 3 of 6 Pages
----- -----
February 3, 2003
Item 1(a). Name of Issuer.
--------- --------------
Rita Medical Systems, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices.
--------- -----------------------------------------------
967 N. Shoreline Blvd.
Mountain View, CA 94043
Item 2(a). Name of Person Filing.
--------- ---------------------
Michael A. Roth and Brian J. Stark, as joint filers
Item 2(b). Address of Principal Business Office or, if None, Residence.
--------- -----------------------------------------------------------
3600 South Lake Drive
St. Francis, WI 53235
Item 2(c). Citizenship.
--------- -----------
United States of America
Item 2(d). Title of Class of Securities.
--------- ----------------------------
Common Stock
Item 2(e). CUSIP Number.
--------- ------------
76774E103
Item 3. If this Statement is Filed pursuant to Rule 13d-1(b), or
------ 13d-2(b) or (c), Check Whether the Person Filing is a:
(a) [ ] Broker or dealer registered under Section 15 of the
Exchange Act.
(b) [ ] Bank as defined in Section 3(a)(6) of the Exchange
Act.
(c) [ ] Insurance company as defined in Section 3(a)(19) of
the Exchange Act.
(e) [ ] Investment company registered under Section 8 of the
Investment Company Act.
(f) [ ] An investment advisor in accordance with Rule
13d-1(b)(1)(ii)(E);
SCHEDULE 13G Page 4 of 6 Pages
----- -----
February 3, 2003
(g) [ ] An employee benefit plan or endowment fund in
accordance with Rule 13d-1(b)(1)(ii)(F);
(h) [ ] A parent holding company or control person in
accordance with Rule 13d-1(b)(1)(ii)(G)
(i) [ ] A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act;
(j) [ ] A church plan that is excluded from the definition of
an investment company under Section 3(c)(14) of
the Investment Company Act;
(k) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J)
If this statement is filed pursuant to Rule 13d-1(c), check
this box. [X]
Item 4. Ownership.
------ ---------
(a) Amount beneficially owned:
1,136,363*
------------------------------------------------------------------
(b) Percent of class:
6.6%*
------------------------------------------------------------------
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote 1,136,363* ,
------------
(ii) Shared power to vote or to direct the vote 0 ,
------------
(iii) Sole power to dispose or to direct the disposition of 1,136,363*,
----------
(iv) Shared power to dispose or direct the disposition of 0 ,
----------
*The foregoing amounts of shares and percentage represent
the combined indirect holdings of Michael A. Roth and Brian
J. Stark, as joint filers. All of the foregoing shares are
held directly by SF Capital Partners, Ltd., a British Virgin
Islands company ("SF Capital"). Messrs. Roth and Stark are
the founding members and direct the management of Staro
Asset Management, L.L.C., a Wisconsin limited liability
company ("Staro") which (i) acts as investment manager and
has sole power to direct the management of Shepherd
Investments International, Ltd., a British Virgin Islands
corporation ("SIIL"), and (ii) acts as general partner and
has sole power to direct the management of Stark Investments
Limited Partnership, a Wisconsin limited partnership
("SILP") which serves as the general partner of Stark
Trading, a Wisconsin general partnership ("ST"). SIIL and ST
are the controlling owners of SF Capital. Through Staro,
Messrs. Roth and Stark possess sole voting and dispositive
power over all of the foregoing shares. Based upon
information provided in the Issuer's Form 10Q for the
quarter ended September 30, 2002, there were 15,143,708
shares of Common Stock issued and outstanding as of November
8, 2002. Therefore, for the purposes of Rule 13d-3 under the
Securities Exchange Act of 1934, Messrs. Roth and Stark may
be deemed to be the beneficial owners of 1,136,363 shares of
Common Stock which represents 6.6% of the Issuer's issued
and outstanding shares of Common Stock.
Item 5. Ownership of Five Percent or Less of a Class.
------ --------------------------------------------
Not applicable.
SCHEDULE 13G Page 5 of 6 Pages
----- -----
February 3, 2003
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
------ ---------------------------------------------------------------
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
------ -----------------------------------------------------------------------
Not applicable.
Item 8. Identification and Classification of Members of the Group.
------ ---------------------------------------------------------
Not applicable.
Item 9. Notice of Dissolution of Group.
------ ------------------------------
Not applicable.
Item 10. Certification.
------- -------------
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
SCHEDULE 13G Page 6 of 6 Pages
----- -----
February 3, 2003
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 3, 2003
/s/ Michael A. Roth
---------------------------
Michael A. Roth
/s/ Brian J. Stark
---------------------------
Brian J. Stark
EXHIBIT 1
AGREEMENT AS TO JOINT FILING
Dated: Februaury 3, 2003
The undersigned hereby agree that the Schedule 13G with respect to Rita
Medical Systems, Inc. dated as of the date hereof, is filed on behalf of each of
the undersigned jointly pursuant to Rule 13d-1(k).
/s/ Michael A. Roth
---------------------------
Michael A. Roth
/s/ Brian J. Stark
---------------------------
Brian J. Stark